Albumin and Furosemide in Nephrotic Syndrome

Comparison of Sequential versus Concurrent Albumin and Furosemide in Pediatric Nephrotic Syndrome Patients

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20120415009475N11

Enrollment

128

Registered

2022-02-22

Start date

2022-02-20

Completion date

Unknown

Last updated

2022-03-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nephrotic syndrome. Nephrotic syndrome

Interventions

Intervention 1: Intervention group: Receives a mixture of albumin and furosemide simultaneously. In this group, 10 milligrams of Furosemide is added to a 50 milliliters vial of Albumin 20 percent and

Eligibility

Sex/Gender

All

Age

2 Years to 15 Years

Inclusion criteria

Inclusion criteria: ??Age between 2 to 15 years Diagnosis of Nephrotic Syndrome

Exclusion criteria

Exclusion criteria: Allergy to Albumin Allergy to Furosemide Urine output less than 0.5 ml/kg/hr

Design outcomes

Primary

Measure	Time frame
Patient weight. Timepoint: 24 hours after intervention. Method of measurement: Weighing the patient.;Urine sodium level. Timepoint: 24 hours after intervention. Method of measurement: urine analysis.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactFatemeh Tadayoni

Islamic Azad University

ph.fatemeh.tadayoni@gmail.com+98 21 5507 8498

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026